No. “Tobacco-free” describes the product; “synthetic” describes the nicotine, and almost every tobacco-free pouch sold today contains nicotine extracted from the tobacco plant. The two phrases get used interchangeably in marketing and in news coverage, but they answer different questions. One is about what is in the tin. The other is about where one ingredient came from before it got there.
This is the most common confusion I see about nicotine pouches, and it is not really the reader’s fault. The phrase that causes it — tobacco-free nicotine — is structurally ambiguous in English. It parses as “tobacco-free [nicotine pouches]” or as “[tobacco-free nicotine] pouches”, and those mean opposite things. Worse, the US regulator and most pouch brands use it in those two opposite senses. So let me take it apart properly.
Two claims about two different things
A nicotine pouch is tobacco-free when the pouch contains no tobacco plant material — no cut, ground, powdered or leaf tobacco. The filler is usually cellulose. That is a claim about the contents of the pouch.
Synthetic nicotine is nicotine built in a laboratory from simpler chemicals rather than extracted from Nicotiana tabacum. That is a claim about the origin of one ingredient.
Those two claims are independent. A pouch can be tobacco-free and contain tobacco-derived nicotine — and the overwhelming majority are. A pouch could in principle contain tobacco leaf and synthetic nicotine, though I am not aware of a product that does. The marketing language collapses the distinction because “tobacco-free” sells better than “we take the nicotine out of tobacco and throw the leaf away”, which is what actually happens.
FDA says it in one sentence, and the brand does not
The cleanest statement of the real position comes from the US regulator, writing about the best-selling pouch on the American market. In its Technical Project Lead review of ZYN’s modified risk applications, signed 29–30 June 2026, FDA writes:
“The applicant describes the proposed MRTPs as 400 mg sealed pouches containing tobacco-derived nicotine in a salt formulation, along with flavor ingredients, an artificial sweetener, stabilizers, fillers, and pH adjusters, and without any whole, cut, or ground tobacco.”
Tobacco-derived and tobacco-free, in the same sentence, from the regulator. The earlier premarket review of the same products, signed 14 January 2025, puts the other half plainly: “The new products are not smokeless tobacco products because they do not consist of cut, ground, powdered, or leaf tobacco.”
What I find more interesting is the asymmetry in who says it. I went through ZYN’s US-facing pages looking for a statement of nicotine source and could not find one. The brand’s US site describes “pharmaceutical-grade nicotine salt” and “food-grade ingredients” and stops there. The UK site does disclose it — but as a footnote. On ZYN’s UK ingredients page (published 27 August 2025, updated 25 November 2025) the body text reads “ZYN does not contain tobacco*, unlike traditional oral smokeless products such as Snus”, and the asterisk resolves to: “*The nicotine in ZYN is derived from tobacco but ZYN does not contain tobacco leaf.”
Both sentences are true. The typography is the point: the claim is the headline, the qualification is the footnote.
The exhibit: one brand, one page, both answers
If you want a single artefact that settles the question, it is VELO’s own US FAQ. Three product lines, all tobacco-free, with their ingredient lists side by side:
“VELO Nicotine Pouches: Nicotine derived from the tobacco plant, maltitol, modified cellulose, sodium carbonates, acesulfame K, and artificial flavor.”
“VELO PLUS Nicotine Pouches: Non-tobacco derived synthetic nicotine, microcrystalline cellulose, sodium carbonates, sucralose, salt, water, and artificial flavor.”
“VELO MAX Nicotine Pouches: Nicotine derived from the tobacco plant, microcrystalline cellulose, benzoates, sucralose, salt, water, and artificial flavor.”
The same page spells it out: “VELO and VELO MAX Nicotine Pouches are oral nicotine products containing tobacco-derived nicotine rather than tobacco leaf”, while “VELO PLUS Nicotine Pouches are oral nicotine products containing synthetic nicotine that is not derived from the tobacco plant.”
Three pouches from one company, on one shelf, all three equally tobacco-free. Two of them tobacco-derived, one synthetic. If the two phrases meant the same thing, that page could not exist.
Rogue’s own help centre shows how the conflation happens in the writing rather than in the product. Its page on nicotine type, dated 9 October 2020, says: “Nicotine is extracted from the tobacco leaf using a steam process, resulting in nicotine that is 100% tobacco leaf-free.” That sentence states the nicotine comes from tobacco and then calls the result tobacco-leaf-free, which is accurate — it is about the material, not the origin — and is also exactly the construction that trains people to hear “tobacco-free” as “not from tobacco”.
Elsewhere the source simply is not stated. I checked Nordic Spirit’s FAQ, which says the pouches are “100% tobacco free” by contrast with snus but says nothing about where the nicotine comes from, and Pablo’s site, which markets “tobacco-free nicotine pouches” and likewise does not say. Altria’s science site is the exception that discloses without being asked: it states that “nicotine pouches contain only tobacco-derived nicotine and non-tobacco ingredients”, which covers its own on! brand.
What the measurements say: eight out of ten
You do not have to take the brands’ word for any of this, because nicotine carries a chemical fingerprint of its origin. Researchers tested ten popular pouch brands and published the results in Nicotine & Tobacco Research in 2026 (Page et al., 28(2):268–276, published online 19 May 2025). The brands were “BRIDGE, FR&Ebar;, Juice Head, LUCY, on!, NIC-S, Rogue, VELO, White Fox, ZYN”.
The finding, verbatim: “Only BRIDGE and FR&Ebar; pouches contained racemic nicotine.” And: “The remaining ONPs and all OTPs contained 100% S-nicotine.”
Translated: eight of the ten tobacco-free pouch brands tested carried nicotine with the chemical signature of the tobacco plant. Two did not. The authors’ own reading is that the two racemic products indicate “their synthetic source”.
One honest caveat about that study. I could not read its funding statement or its declaration of interests — the publisher’s article page does not render either section, and I tried seven times across two routes. On this site the funding is part of the result, so I am telling you I do not have it rather than implying there was nothing to disclose. The brand-level findings are what I am citing; weigh them accordingly.
The chemistry, and why it is a good clue but not a proof
Nicotine is chiral: it comes in two mirror-image forms, (S) and (R). In the plant, one of them dominates. A 2024 synthesis paper in Molecules notes that the leaves of Nicotiana tabacum “consist of 93% of (S)-nicotine in a mixture of its alkaloids”, and that “(S)-nicotine is more biologically active than its isomer (R)”.
The classical laboratory route runs through myosmine and produces a roughly even mixture of both forms. So a 50/50 result points to a synthetic origin and a near-pure (S) result points to the plant. Measured on supplier raw materials by chiral supercritical fluid chromatography, the gap is stark: one synthetic lot came back at an R/S ratio of 0.92, essentially equal amounts of both, while a tobacco-derived lot came back at 0.0059 (Ashraf-Khorassani et al., Journal of Chromatographic Science 62(5):492–497, 2024). Two orders of magnitude apart. Those were raw nicotine lots, not finished pouches, and the paper carries neither a funding statement nor a competing-interests statement — I checked for both, and their absence is itself worth knowing.
Here is where I would push back on the tidy version of this story. “Synthetic means racemic” is no longer reliably true. Modern stereoselective routes make enantiopure (S)-nicotine synthetically; the Molecules paper exists precisely because industry wants that. Its funding line reads: “The A-Sense Sp. z o.o. realizing the project FENG.01.01-IP.02-002/23 of Polish Agency for Enterprise Development et. ‘Launch of Nicxperience–synthetic nicotine for pharmaceutical applications’.” The paper then declares “The authors declare no conflicts of interest.” I will let you hold those two sentences next to each other.
So the enantiomer ratio is a useful forensic marker, not a definition. A racemic result tells you the nicotine was made, not grown. A pure-(S) result is consistent with the plant and no longer rules out a well-made synthetic.
And the obvious follow-up question — whether the (R) form behaves differently in the body — has no regulatory answer at all. I searched for it in BfR’s nicotine pouch risk assessment (Opinion 027/2021, 20 September 2021) and confirmed that neither “enantiomer” nor “racemic” appears anywhere in the document. The same silence runs through the other regulator material I have read on pouches. That is not a reassurance and it is not an alarm. It is a gap.
In 2022 the law stopped caring where the nicotine came from
The reason this distinction once mattered commercially is that it used to be a regulatory loophole in the United States. FDA’s authority ran to products “made or derived from tobacco”, so a synthetic-nicotine product arguably sat outside it. Several companies used that.
Congress closed it. Section 111 of the Consolidated Appropriations Act, 2022 inserted five words into 21 U.S.C. § 321(rr)(1), which now reads:
“The term ‘tobacco product’ means any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption…”
The amendment note is as blunt as drafting gets: “Pub. L. 117–103, §111(a)(1), inserted ‘, or containing nicotine from any source,’ after ‘from tobacco’.” It took effect 30 days after enactment — 14 April 2022 — and FDA confirmed in its own words that “any new non-tobacco nicotine product that has not received premarket authorization from FDA cannot be legally marketed” after 13 July 2022.
What the amendment did not touch is the definition of “smokeless tobacco” at 21 U.S.C. § 387(18), which still requires “cut, ground, powdered, or leaf tobacco”. That is the material test, and it is why FDA could write that ZYN is a tobacco product but not a smokeless tobacco product. It also explains why a pouch does not carry the mouth-cancer and gum-disease warnings that a tin of dip does: those attach under the Comprehensive Smokeless Tobacco Health Education Act, which borrows the § 387(18) definition. A pouch with no tobacco material falls outside it — and that is true whether its nicotine is synthetic or tobacco-derived. The absence of leaf does the work, not the origin of the molecule.
Europe and Britain never cared about source at all
The European position is differently shaped and worth knowing if you buy across borders. Directive 2014/40/EU defines “tobacco products” at Article 2(4) as “products that can be consumed and consist, even partly, of tobacco, whether genetically modified or not”. The word “nicotine” does not appear in that definition. It is a pure material test.
So a tobacco-free pouch does not consist even partly of tobacco, is therefore not a tobacco product under the Directive, and falls outside the whole instrument — including the Article 17 oral-tobacco ban. BfR put the consequence plainly: “Nicotine pouches are not subject to tobacco law, so there is no obligation for manufacturers to notify the European registration system EU-CEG.” Which is why pouches in the EU are governed by twenty-seven different national regimes rather than one directive. I have written separately about why snus is banned across the EU but legal in Sweden, which turns on the same Article.
Britain’s Tobacco and Vapes Act 2026 does something neater: it runs both tests in one Act. Section 116 defines a “tobacco product” as “a product consisting wholly or partly of tobacco and intended to be smoked, sniffed, sucked, chewed or consumed in any other way” — material test. Section 117 then defines a “nicotine product” to include “nicotine, or any substance containing nicotine, which is intended to be delivered into the human body”, excluding anything that is already a tobacco product. That definition says nothing whatever about where the nicotine came from.
Line the three up and the pattern is clear. The material test — is there leaf in it? — decides which bucket a pouch lands in, in all three jurisdictions. The source of the nicotine decides nothing anywhere, and has decided nothing in the US since April 2022.
What this actually changes for you
Less than the marketing implies, which is rather the point.
A tobacco-free pouch does not contain tobacco. That is a real, verifiable difference from snus or dip, and it is the difference that drives the measured contrast in tobacco-specific nitrosamines. Whether the nicotine inside it was grown or built does not change how it is regulated, does not change the pouch’s labelled strength, and has no published toxicological consequence that any regulator has set out.
What it does change is your ability to read a claim. “Tobacco-free” on a tin is almost certainly true and tells you about the filler. “Tobacco-free nicotine” is a phrase I would treat as unreadable without checking the ingredient list, because the brand and the regulator may well mean opposite things by it. If a brand does not state the nicotine source on its own site — and most do not — the safe default assumption is tobacco-derived, because that is what eight of ten measured brands turned out to be.
The six brands, compared
| Brand | Does its own site state the nicotine source? | What it says | Tobacco-free pouch? |
|---|---|---|---|
| VELO (US) | Yes | “Nicotine derived from the tobacco plant” | Yes |
| VELO PLUS (US) | Yes | “Non-tobacco derived synthetic nicotine” | Yes |
| VELO MAX (US) | Yes | “Nicotine derived from the tobacco plant” | Yes |
| ZYN (US site) | No | “pharmaceutical-grade nicotine salt”; source not stated | Yes |
| ZYN (UK site) | Yes, in a footnote | “*The nicotine in ZYN is derived from tobacco but ZYN does not contain tobacco leaf” | Yes |
| Rogue | Yes | “Nicotine is extracted from the tobacco leaf using a steam process” | Yes |
| on! (via Altria Science) | Yes | “only tobacco-derived nicotine and non-tobacco ingredients” | Yes |
| Nordic Spirit | No | “100% tobacco free”; source not stated | Yes |
| Pablo | No | “tobacco-free nicotine pouches”; source not stated | Yes |
Four of nine entries disclose plainly, one discloses in a footnote on one market’s site only, and four do not disclose at all. The regulator discloses more than most of the brands do.
Frequently asked questions
Is synthetic nicotine safer than tobacco-derived nicotine?
No regulator has published an assessment that would let anyone answer that. Nicotine is addictive whatever its origin, and no nicotine product is safe. The one chemical difference that has been measured — the proportion of the (R) form — has no published toxicological evaluation from FDA, BfR or the UK committees that I could find.
Does tobacco-derived nicotine mean there is tobacco in my pouch?
No. The nicotine is extracted and purified; the leaf is not in the pouch. FDA’s own review describes ZYN as containing tobacco-derived nicotine “without any whole, cut, or ground tobacco”. That is also why pouches and snus measure so differently on tobacco-specific nitrosamines — those come from the leaf.
Which pouches actually use synthetic nicotine?
Of the brands I can source from their own sites or from published measurement: VELO PLUS states synthetic nicotine outright, and BRIDGE and FR&Ebar; measured as racemic in the 2026 Nicotine & Tobacco Research study. Everything else I checked was either stated as tobacco-derived or measured as 100% (S)-nicotine.
Why do brands say “tobacco-free” if the nicotine comes from tobacco?
Because it is accurate about the product. The claim is about pouch contents, not ingredient history. It becomes misleading only when it is written as “tobacco-free nicotine”, which says something different and usually is not what the brand means.
Did the 2022 US law ban synthetic nicotine?
No. It brought synthetic-nicotine products inside FDA’s tobacco authority, so they need premarket authorisation like any other. The effect was that unauthorised products could no longer be legally marketed after 13 July 2022.
Does any of this change how a pouch feels?
Not by itself. What you feel is driven by dose, pH and format far more than by the provenance of the molecule — I have written about that in pouch pH and why it changes the hit and nicotine salts vs freebase nicotine.
If you are new to the category, start with nicotine pouches explained and the 3mg tier. For the vocabulary, the glossary has the rest of it, and what is a prilla covers the Swedish side of it, and the master ranking covers what I would actually buy.
Sources
- FDA, Technical Project Lead (TPL) Review of MRTPAs, ZYN nicotine pouches, signed 29–30 June 2026.
- FDA, Technical Project Lead (TPL) Review of PMTAs, STN.PDs PM0000593.PD1–PM0000612.PD1, signed 14 January 2025.
- 21 U.S.C. § 321(rr), as amended by Pub. L. 117–103, div. P, tit. I, § 111, 15 March 2022; effective 14 April 2022.
- FDA, FDA Continues to Implement Law, Regulate Non-Tobacco Nicotine Products, 13 July 2022.
- Directive 2014/40/EU, Articles 2(4), 2(5), 2(8) and 17.
- Tobacco and Vapes Act 2026 c. 18, sections 116 and 117.
- BfR, Preliminary health risk assessment of nicotine pouches, Opinion No. 027/2021, 20 September 2021.
- Page MK et al., Comparison of Nicotine and Selected Flavoring Contents Between Tobacco-Free and Tobacco-Containing Oral Pouches, Nicotine & Tobacco Research 2026;28(2):268–276. Funding and declaration of interests not retrievable from the publisher’s article page.
- Ashraf-Khorassani M et al., Qualitative and quantitative analyses of the enantiomers of nicotine and nornicotine employing chiral supercritical fluid chromatography, Journal of Chromatographic Science 2024;62(5):492–497. No funding statement and no competing-interests statement present.
- Trotsko N et al., Efficient Method of (S)-Nicotine Synthesis, Molecules 2024;29:5731. Funded by A-Sense Sp. z o.o. under a Polish Agency for Enterprise Development project to launch synthetic nicotine; authors declare no conflicts of interest.
- VELO US FAQ; ZYN UK, “What is in a Nicotine Pouch?”, 27 August 2025, updated 25 November 2025; Rogue help centre, 9 October 2020; Nordic Spirit FAQ; Pablo; Altria Science, modern oral nicotine pouches.
Last verified 7 October 2026.